|
|
|
|
LEADER |
01767nam a22003495i 4500 |
001 |
000293626 |
005 |
20211008102907.0 |
007 |
cr nn 008mamaa |
008 |
150422s2015 gw | s |||| 0|eng d |
020 |
|
|
|a 9783319185187
|
024 |
7 |
|
|a 10.1007/978-3-319-18518-7
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
4 |
|a The Future of HIV-1 Therapeutics :
|b Resistance Is Futile? /
|c edited by Bruce E. Torbett, David S. Goodsell, Douglas D. Richman.
|
250 |
|
|
|a 1st ed. 2015.
|
260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2015.
|
300 |
|
|
|a X, 254 p. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Current Topics in Microbiology and Immunology,
|v 389
|
505 |
0 |
|
|a HIV Therapy Looking Towards the Future -- Computational challenges of structure-based approaches applied to HIV -- Nucleocapsid Protein: A Desirable Target For Future Therapies Against HIV-1 -- HIV-1 integrase multimerization as a therapeutic target -- Targeting HIV transcription: The quest for a functional cure -- Targeting the HIV RNA Genome: High-Hanging Fruit Only Needs a Longer Ladder -- HIV-1 Gag: An Emerging Target for Antiretroviral Therapy -- The Triple Threat of HIV-1 Protease Inhibitors -- Illustrations of the HIV Life Cycle.
|
650 |
|
0 |
|a Drug resistance.
|
650 |
|
0 |
|a Virology.
|
650 |
|
0 |
|a Infectious diseases.
|
650 |
1 |
4 |
|a Drug Resistance.
|
650 |
2 |
4 |
|a Virology.
|
650 |
2 |
4 |
|a Infectious Diseases.
|
700 |
1 |
|
|a Torbett, Bruce E.
|e editor.
|
700 |
1 |
|
|a Goodsell, David S.
|e editor.
|
700 |
1 |
|
|a Richman, Douglas D.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|